Skip to main content
Top
Published in: Cancer Cell International 1/2019

Open Access 01-12-2019 | Confusion | Correction

Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases

Authors: Matteo Fassan, Luca Vianello, Diana Sacchi, Giuseppe N. Fanelli, Giada Munari, Marco Scarpa, Rocco Cappellesso, Fotios Loupakis, Cristiano Lanza, Roberta Salmaso, Claudia Mescoli, Nicola Valeri, Marco Agostini, Edoardo D’Angelo, Sara Lonardi, Salvatore Pucciarelli, Nicola Veronese, Claudio Luchini, Massimo Rugge

Published in: Cancer Cell International | Issue 1/2019

Login to get access

Excerpt

Following publication of the original article [1], it has been brought to our attention that an incorrect Sequenom MassArray trace and an incorrect nomenclature were used to represent the PIK3CA p.E545A mutation in Fig. 2b. The correct Fig. 2b is shown in this erratum. The authors apologize for the confusion.
Literature
1.
go back to reference Fassan M, Vianello L, Sacchi D, Fanelli GN, Munari G, Scarpa M, Cappellesso R, Loupakis F, Lanza C, Salmaso R, Mescoli C, Valeri N, Agostini M, D’Angelo E, Lonardi S, Pucciarelli S, Veronese N, Luchini C, Rugge M. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer Cell Int. 2018;18:131. https://doi.org/10.1186/s12935-018-0634-8.CrossRefPubMedPubMedCentral Fassan M, Vianello L, Sacchi D, Fanelli GN, Munari G, Scarpa M, Cappellesso R, Loupakis F, Lanza C, Salmaso R, Mescoli C, Valeri N, Agostini M, D’Angelo E, Lonardi S, Pucciarelli S, Veronese N, Luchini C, Rugge M. Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases. Cancer Cell Int. 2018;18:131. https://​doi.​org/​10.​1186/​s12935-018-0634-8.CrossRefPubMedPubMedCentral
Metadata
Title
Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
Authors
Matteo Fassan
Luca Vianello
Diana Sacchi
Giuseppe N. Fanelli
Giada Munari
Marco Scarpa
Rocco Cappellesso
Fotios Loupakis
Cristiano Lanza
Roberta Salmaso
Claudia Mescoli
Nicola Valeri
Marco Agostini
Edoardo D’Angelo
Sara Lonardi
Salvatore Pucciarelli
Nicola Veronese
Claudio Luchini
Massimo Rugge
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Confusion
Published in
Cancer Cell International / Issue 1/2019
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-019-0966-z

Other articles of this Issue 1/2019

Cancer Cell International 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine